Agronomics
We invest in opportunities within the Life Science sector, concentrating on, but not limited to, environmentally friendly alternatives to the traditional production of meat and plant-based nutrition sources such as cellular agriculture, cellular aquaculture and the alternative protein space. We focus on investments that provide scalable and commercially viable opportunities.
London, United KingdomFounded 2019
Finance
Coverage
Featured In
Digest
Meatly raises £10.4M for cell-cultured facility; Beyond Meat narrows loss; U.S. meat sales hit $112 billion
Digest
Parima wins Singapore cell-cultured duck approval; BRIGHT and Novonesis partner on CO₂-to-protein fermentation
Article
Investing in the cultured meat industry: An independent analysis of Agronomics
Article
Investing in the new agrarian revolution: an interview with Jim Mellon
Article